Zhejiang Xindonggang Pharmaceutical

Zhejiang Xindonggang Pharmaceutical is a leading Chinese pharmaceutical enterprise focused on the development and manufacturing of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. As a key subsidiary of Huadong Medicine, the company has established itself as a global powerhouse in the production of statins, including atorvastatin, rosuvastatin, and pitavastatin. Their state-of-the-art facilities hold multiple international certifications, including US FDA and EU GMP, enabling them to supply regulated markets worldwide. Beyond cardiovascular health, Xindonggang's portfolio encompasses anti-infectives, central nervous system medications, and anti-diabetic agents. The company integrates advanced chemical synthesis technologies to maintain a competitive edge in the global generic drug supply chain. It serves as one of the largest production bases for cardiovascular drugs in China, supporting both domestic and international healthcare needs.